Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with rheumatoid arthritis (RA) according to recognised medical guidelines
- Your overall disease impact score (as rated by your doctor) is 40mm or higher on a standard scale
- You are between 18 and 64 years old
- You are motivated and willing to take part in the intervention
- You are able to understand the study and actively participate in it
- Your RA disease activity score (called DAS28-CRP) is 3.2 or below, meaning your condition is currently low or in remission
- You are able to use a smartphone app called RB4.1
Who may not be able to join:
- You have dementia or any other condition affecting your thinking, communication, or physical ability that would prevent participation
- You have a vision impairment that would prevent you from using the required devices or computer
- Your RA medication (called a DMARD) has been changed within the last 8 weeks
- You have been diagnosed with chronic widespread pain or fibromyalgia
- You currently have an active infection
- You have severe asthma
- You have severe chronic obstructive pulmonary disease (a serious lung condition) (confirm with trial site)
- You have an unstable heart condition
- You are currently receiving intensive physiotherapy beyond standard care
- You are currently receiving electrostimulation therapy
- You are currently receiving motivation training
- You are a smoker
- You currently have a fever
- Your doctor considers your pain or fatigue to be a side effect of your treatment
- You have another autoimmune disease
- You have a diagnosed mental health condition
- You are receiving any other non-medication-based therapies that your doctor thinks could affect your RA
- You have any other health condition that, in the investigator's opinion, could affect the trial or its results (confirm with trial site)
- You have previously used any health apps specifically related to managing rheumatoid arthritis
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Henning Bliddal, The Parker Institute, Bispebjerg and Frederiksberg Hospital
Phone: +4538164173
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Patient Global Assessment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.